QUANTIFICATION OF APOLIPOPROTEIN A-IV IN HUMAN PLASMA BY IMMUNONEPHELOMETRY

被引:0
|
作者
SCHWARZ, S
HAAS, B
LULEY, C
SCHAFER, JR
STEINMETZ, A
机构
[1] UNIV MARBURG,ZENTRUM INNERE MED,ENDOKRINOL & STOFFWECHSEL ABT,D-35033 MARBURG,GERMANY
[2] UNIV FREIBURG,KLIN CHEM ABT,D-79106 FREIBURG,GERMANY
关键词
LIPOPROTEINS; ATHEROSCLEROSIS; ELECTROIMMUNODIFFUSION COMPARED; TRIGLYCERIDES; SAMPLE HANDLING;
D O I
暂无
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
We developed a nephelometric procedure for determining concentrations of human plasma apolipoprotein (ape) A-IV. Results obtained correlate well with those measured by an established electroimmunodiffusion assay (r = 0.98; n = 56). Intra- and interassay CVs were 2.4% and 2.0%, respectively, indicating excellent precision and reproducibility. Various conditions of sample treatment, such as adequate storage, freezing, and thawing, did not affect results significantly. However, keeping samples at room temperature for 4 days led to a slight increase in measured values. Preincubation with a cholesterinesterase-detergent mixture abolished interference from triglyceride-rich lipoproteins, allowing assay of samples containing triglycerides as great as 10 g/L. The assay is easily applicable to clinical laboratories for routine diagnostic use, as shown with hypertriglyceridemic plasmas and samples with a broad range of apo A-IV concentrations.
引用
收藏
页码:1717 / 1721
页数:5
相关论文
共 50 条
  • [41] Hypothalamic apolipoprotein A-IV is regulated by leptin
    Shen, Ling
    Tso, Patrick
    Woods, Stephen C.
    Sakai, Randall R.
    Davidson, W. Sean
    Liu, Min
    ENDOCRINOLOGY, 2007, 148 (06) : 2681 - 2689
  • [42] Inhibition of Vascular Inflammation by Apolipoprotein A-IV
    Shearston, Kate
    Tan, Joanne T. M.
    Cochran, Blake J.
    Rye, Kerry-Anne
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2022, 9
  • [43] Apolipoprotein A-IV Associated Cardiac Amyloidosis
    Bois, Melanie C.
    Dasari, Surendra
    Theis, Jason D.
    Vrana, Julie
    Grogan, Martha
    Dispenzieri, Angela
    Kurtin, Paul J.
    Maleszewski, Joseph J.
    LABORATORY INVESTIGATION, 2016, 96 : 81A - 82A
  • [44] Apolipoprotein A-IV inhibits experimental colitis
    Vowinkel, T
    Mori, M
    Krieglstein, CF
    Russell, J
    Saijo, F
    Bharwani, S
    Turnage, RH
    Davidson, WS
    Tso, P
    Granger, DN
    Kalogeris, TJ
    JOURNAL OF CLINICAL INVESTIGATION, 2004, 114 (02): : 260 - 269
  • [45] Apolipoprotein A-IV enhances cholecystokinnin secretion
    Zhan, Jesse
    Weng, Jonathan
    Hunt, Brian G.
    Davidson, W. Sean
    Liu, Min
    Le, Chunmin C.
    PHYSIOLOGY & BEHAVIOR, 2018, 188 : 11 - 17
  • [46] Apolipoprotein A-IV in the fed and fasting states
    Rafat, N
    Sattler, AM
    Hackler, R
    Soufi, M
    Steinmetz, A
    Maisch, B
    Schaefer, JR
    CLINICAL CHEMISTRY, 2004, 50 (07) : 1270 - 1271
  • [47] Gastrointestinal satiety signals - IV. Apolipoprotein A-IV
    Tso, P
    Sun, W
    Liu, M
    AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY, 2004, 286 (06): : G885 - G890
  • [48] APOLIPOPROTEIN A-IV IN DIABETES-MELLITUS
    VERGES, B
    DIABETES & METABOLISM, 1995, 21 (02): : 99 - 105
  • [49] Role of Conserved Proline Residues in Human Apolipoprotein A-IV Structure and Function
    Deng, Xiaodi
    Walker, Ryan G.
    Morris, Jamie
    Davidson, W. Sean
    Thompson, Thomas B.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2015, 290 (17) : 10689 - 10702
  • [50] 3 DIFFERENT INSERTION POLYMORPHISMS 3' TO THE HUMAN APOLIPOPROTEIN A-IV GENE
    CIVEIRA, F
    CASSIDY, DK
    SCHAEFER, EJ
    ORDOVAS, JM
    NUCLEIC ACIDS RESEARCH, 1989, 17 (15) : 6428 - 6428